Editor LSA

OTC Market's Gainers and Laggards - ScripsAmerica, Inc., Affymax, Inc., Nuvilex Inc, North American Oil & Gas Corp


Lewes, DE -- (SBWIRE) -- 07/17/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: ScripsAmerica, Inc. (OTCBB:SCRC), Affymax, Inc. (OTCMKTS:AFFY), Nuvilex Inc (OTCMKTS:NVLX), North American Oil & Gas Corp (OTCBB:NAMG)

ScripsAmerica, Inc. (OTCBB:SCRC) gained 19.04%, trading on 685,718 shares to end the trade at $0.619. The stock changed hands in a range of $0.54 to $0.65, bringing its market capitalization at about $34.91 million. If we look at its trading history of past 52 weeks, the share price suffered low of $0.11 and was moved to maximum level of $1.05. ScripsAmerica, Inc. engages in the distribution of pharmaceutical products in the United States. It delivers pharmaceutical products, including pain, arthritis, prenatal, urinary, and hormonal replacement drugs to a range of customers across the health care industry, including physician offices, retail pharmacies, long-term care sites, hospitals, and Government and home care agencies. The company was founded in 2008 and is based in New Castle, Delaware.

For How Long SCRC will fight for Profitability? Read This Trend Analysis report

Affymax, Inc. (OTCMKTS:AFFY) declined -0.74% to complete the trading session at $1.07 with a total volume of 363,960 shares. The stock, on average, trades on a volume of 2.96 million shares. It floated in a range of $1.05 to $1.08 during last trading session with a beta value of 1.28. Its market capitalization now moved to about $40.19 million. In the past 52 weeks, the share price has not declined below $0.78 and above $27.74. Affymax, Inc., a biopharmaceutical company, engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life-threatening illnesses.

Has AFFY Found The Bottom And Ready To Gain Momentum? Find Out Here

Nuvilex Inc (OTCMKTS:NVLX) recorded a fall of -4.83% and was in a range of $0.14-$0.15 before closing at $0.138. The stock completed the day with a total volume of 2.39 million shares versus an average volume of 1.44 million shares. The share price hit its 52-week low of $0.02 and $0.22 was the best price. Nuvilex, Inc, a biotechnology and life technology company, engages in the development and marketing of products for enhancing the health and well-being worldwide. The company?s products include Cinnechol, a natural supplement to help maintain normal cholesterol levels and to support normal cardiovascular function

Why Should Investors Buy NVLX After the Recent Fall? Just Go Here and Find Out

North American Oil & Gas Corp (OTCBB:NAMG) added 7% yesterday, bringing its market capitalization around $64.33 million. The share price after opening at $1.03 made a high of $1.09 and hovered above $0.91 to end the day at $1.07. The total number of shares changed hands during the session was 307,600 shares as compared to average trading volume of 10,387 shares. North American Oil & Gas Corp., formerly Calendar Dragon Inc., is a development-stage company. The Company was formed to create a new calendaring tool that incorporates a range of features not offered by other providers, all in one lean online package.

For How Long NAMG Gloss will Attract Investors? Find out via this report

About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/